Cardiovascular outcomes and mortality after initiation of canagliflozin: Analyses from the EASEL Study

INTRODUCTION: In the EASEL study of patients with type 2 diabetes and high cardiovascular risk, initiation of sodium glucose co‐transporter 2 inhibitors (SGLT2i) was associated with lower risk of cardiovascular events and mortality and higher risk of below‐knee lower extremity (BKLE) amputation vers...

Descripción completa

Detalles Bibliográficos
Autores principales: Udell, Jacob A., Yuan, Zhong, Ryan, Patrick, Rush, Toni, Sicignano, Nicholas M., Galitz, Michael, Rosenthal, Norman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947703/
https://www.ncbi.nlm.nih.gov/pubmed/31922023
http://dx.doi.org/10.1002/edm2.96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947703/
https://www.ncbi.nlm.nih.gov/pubmed/31922023
http://dx.doi.org/10.1002/edm2.96

Ejemplares similares